Compare HESM & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HESM | LIVN |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.3B |
| IPO Year | 2019 | 2015 |
| Metric | HESM | LIVN |
|---|---|---|
| Price | $32.75 | $78.83 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $33.43 | ★ $90.55 |
| AVG Volume (30 Days) | ★ 3.1M | 517.2K |
| Earning Date | 10-30-2026 | 11-04-2026 |
| Dividend Yield | ★ 9.78% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.33 |
| Revenue | ★ $1,621,300,000.00 | N/A |
| Revenue This Year | N/A | $9.65 |
| Revenue Next Year | N/A | $7.10 |
| P/E Ratio | ★ $13.07 | $35.01 |
| Revenue Growth | ★ 8.41 | N/A |
| 52 Week Low | $29.52 | $48.82 |
| 52 Week High | $41.44 | $85.76 |
| Indicator | HESM | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 50.35 |
| Support Level | $29.52 | $74.69 |
| Resistance Level | $40.77 | $82.39 |
| Average True Range (ATR) | 0.84 | 2.20 |
| MACD | 0.39 | 0.26 |
| Stochastic Oscillator | 75.51 | 48.00 |
Hess Midstream LP is a fee-based, growth-oriented limited partnership that owns, operates, develops, and acquires a portfolio of midstream assets. The company provides fee-based services to Chevron Corporation and generates all of its revenue by charging fees for gathering, compressing, and processing natural gas, fractionating NGLs, gathering, terminaling, loading, and transporting crude oil and NGLs, storing and terminaling propane, and gathering and disposing of produced water. It operates through gathering, processing, and storage, and terminaling and export segments, with the gathering segment contributing the maximum share of revenue and comprising natural gas gathering and compression, as well as crude oil gathering and produced water gathering and disposal assets.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.